Lakeland Industries (NASDAQ:LAKE) Rating Increased to Sell at StockNews.com

Lakeland Industries (NASDAQ:LAKE - Get Free Report) was upgraded by investment analysts at StockNews.com to a "sell" rating in a research report issued on Wednesday.

Other equities analysts have also issued reports about the company. Lake Street Capital started coverage on Lakeland Industries in a research report on Tuesday, March 11th. They set a "buy" rating and a $30.00 price target on the stock. DA Davidson reduced their price target on Lakeland Industries from $28.00 to $23.00 and set a "buy" rating on the stock in a research report on Tuesday, April 15th. One research analyst has rated the stock with a sell rating and four have given a buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $27.00.

Lakeland Industries Price Performance

Shares of NASDAQ LAKE traded down $0.22 during trading hours on Wednesday, reaching $16.59. 59,473 shares of the stock traded hands, compared to its average volume of 62,238. The company has a market capitalization of $157.59 million, a P/E ratio of -184.33 and a beta of 0.86. The company has a quick ratio of 1.77, a current ratio of 4.23 and a debt-to-equity ratio of 0.25. Lakeland Industries has a 52-week low of $14.58 and a 52-week high of $27.28. The company's 50-day simple moving average is $19.31 and its two-hundred day simple moving average is $21.59.

Lakeland Industries (NASDAQ:LAKE - Get Free Report) last announced its quarterly earnings data on Wednesday, April 9th. The medical instruments supplier reported ($0.54) earnings per share for the quarter, missing analysts' consensus estimates of $0.43 by ($0.97). The firm had revenue of $46.60 million for the quarter, compared to analysts' expectations of $47.10 million. Lakeland Industries had a negative net margin of 0.42% and a positive return on equity of 1.66%. During the same period in the prior year, the business posted $0.72 earnings per share. Equities research analysts forecast that Lakeland Industries will post 0.48 EPS for the current year.

Institutional Investors Weigh In On Lakeland Industries

A number of large investors have recently made changes to their positions in LAKE. Barclays PLC bought a new stake in shares of Lakeland Industries in the 3rd quarter worth approximately $306,000. Geode Capital Management LLC grew its position in shares of Lakeland Industries by 1.6% in the 3rd quarter. Geode Capital Management LLC now owns 74,273 shares of the medical instruments supplier's stock worth $1,493,000 after buying an additional 1,177 shares during the last quarter. Diversified Investment Strategies LLC grew its position in shares of Lakeland Industries by 30.0% in the 4th quarter. Diversified Investment Strategies LLC now owns 32,500 shares of the medical instruments supplier's stock worth $830,000 after buying an additional 7,500 shares during the last quarter. Peapod Lane Capital LLC bought a new stake in shares of Lakeland Industries during the fourth quarter valued at approximately $2,018,000. Finally, D.A. Davidson & CO. grew its stake in Lakeland Industries by 1.6% in the fourth quarter. D.A. Davidson & CO. now owns 43,892 shares of the medical instruments supplier's stock worth $1,121,000 after purchasing an additional 698 shares during the period. 71.69% of the stock is currently owned by institutional investors.

About Lakeland Industries

Lakeland Industries, Inc manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks.